Stockscreener 앱 받기
1.52
1.94%
-0.03
전일 마감가:
$1.55
열려 있는:
$1.6
하루 거래량:
176.76K
Relative Volume:
1.38
시가총액:
$17.36M
수익:
$14.58M
순이익/손실:
$-12.57M
주가수익비율:
-0.2676
EPS:
-5.68
순현금흐름:
$-13.07M
1주 성능:
-1.94%
1개월 성능:
-22.05%
6개월 성능:
-67.03%
1년 성능:
-64.24%
1일 변동 폭
$1.51
$1.7245
1주일 범위
$1.51
$1.88
52주 변동 폭
$1.4235
$7.95
비보스 테라퓨틱스 Stock (VVOS) Company Profile
명칭
Vivos Therapeutics Inc
전화
(866)908-4867
주소
7921 SOUTHPARK PLAZA,, LITTLETON
Compare VVOS vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VVOS
Vivos Therapeutics Inc
|
1.52 | 17.70M | 14.58M | -12.57M | -13.07M | -5.68 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
비보스 테라퓨틱스 주식(VVOS)의 최신 뉴스
What are Vivos Therapeutics Inc.’s earnings expectations2025 Price Targets & Low Risk High Reward Trade Ideas - mfd.ru
Retail Surge: Can Vivos Therapeutics Inc maintain its current growth rate2025 Valuation Update & Real-Time Buy Signal Notifications - baoquankhu1.vn
Is Vivos Therapeutics Inc. showing insider buying2025 Price Targets & Verified Swing Trading Watchlists - mfd.ru
VIX Spike: How does Vivos Therapeutics Inc score in quality rankingsEarnings Growth Report & Expert Curated Trade Setups - baoquankhu1.vn
Will Vivos Therapeutics Inc. benefit from government policyDollar Strength & Weekly Top Stock Performers List - mfd.ru
Gap Down: Is Vivos Therapeutics Inc part of any ETF2025 Technical Overview & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Earnings Update: How correlated is Vivos Therapeutics Inc to the S P5002025 Macro Impact & Fast Moving Trade Plans - baoquankhu1.vn
Vivos Therapeutics Appoints Gregg Johnson to Board - TipRanks
Vivos Therapeutics Appoints Gregg C. E. Johnson to Board of Directors - TradingView
Vivos Therapeutics, Inc. Appoints Gregg C. E. Johnson as Independent Director of the Board and Compensation Committee of the Board, Effective February 4, 2026 - marketscreener.com
Vivos Therapeutics to Distribute SoundHealth’s FDA-Cleared Sonu and Spatial Sleep Bands - HIT Consultant
Buyout Rumor: Will Vivos Therapeutics Inc benefit from government policyJuly 2025 Final Week & Stock Market Timing Techniques - baoquankhu1.vn
Vivos Therapeutics and SoundHealth collaborate to expand access to groundbreaking FDA-cleared allergy and sleep technologies - marketscreener.com
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies - The Manila Times
Vivos Therapeutics Collaborates with SoundHealth to Enhance Airway and Sleep Health Solutions - Quiver Quantitative
Sound-based allergy and sleep bands join Vivos dentist network - Stock Titan
VIVOS Therapeutics, Inc. ($VVOS) Signs 12-Part Media Series with New to The Street - Eagle-Tribune
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Benzinga
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Receives $4.92 Consensus PT from Brokerages - Defense World
Treasury Yields: Is Vivos Therapeutics Inc part of any ETFQuarterly Market Review & Expert Approved Momentum Ideas - baoquankhu1.vn
Aug Catalysts: Is Vivos Therapeutics Inc showing insider buyingNew Guidance & Safe Entry Momentum Stock Tips - baoquankhu1.vn
What dividend growth rate does Vivos Therapeutics Inc. offer2025 AllTime Highs & Verified Stock Trade Ideas - mfd.ru
Income Plays: What is the PEG ratio of CHSCNMarket Risk Analysis & Reliable Price Breakout Alerts - baoquankhu1.vn
Global Sleep Apnea Devices Market is Expected to Cross the USD 15 Billion Mark by 2032 | DelveInsight - GlobeNewswire Inc.
Vivos Therapeutics Closes Exercise of 1.98M Warrants, Raising $4.64M - intellectia.ai
Vivos Therapeutics, Inc. Closes Exercise of Warrants Raising Approximately $4.64 Million for Working Capital - Quiver Quantitative
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds - The Manila Times
Sleep apnea device maker Vivos raises $4.64M in repriced warrant deal - Stock Titan
Vivos Therapeutics Completes Warrant Inducement Financing Transaction - TipRanks
Vivos Therapeutics Signs Warrant Inducement Agreement With Institutional Investor - TradingView
Chipmakers Recap: What is the dividend yield of Vivos Therapeutics IncAnalyst Upgrade & Low Risk High Reward Ideas - baoquankhu1.vn
Vivos Therapeutics (NASDAQ:VVOS) and Akebia Therapeutics (NASDAQ:AKBA) Head to Head Contrast - Defense World
Vivos Announces Warrant Exercise Agreement - Dentistry Today
Vivos Therapeutics announces exercise of warrants for $4.64M gross proceeds - MSN
Vivos Therapeutics announces $4.64 million warrant exercise deal By Investing.com - Investing.com Nigeria
Vivos Therapeutics Secures Convertible Bridge Financing Facility - TipRanks
Vivos Therapeutics Signs Convertible Note Agreement With V-Co Investors 3 - TradingView
Vivos Therapeutics announces $4.64 million warrant exercise deal - Investing.com India
Vivos Therapeutics (VVOS) Exercises Warrants for $4.64M in Funding - Intellectia AI
Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds - The Manila Times
Sleep apnea device maker Vivos secures $4.64M from warrant exercise - Stock Titan
Dividend Watch: Is The Oncology Institute Inc Equity Warrants ROE strong enoughWeekly Earnings Recap & Weekly Momentum Picks - baoquankhu1.vn
Aug Summary: Is Vivos Therapeutics Inc part of any ETF2025 EndofYear Setup & Real-Time Volume Spike Alerts - baoquankhu1.vn
Alliance Global Partners Sticks to Its Hold Rating for Vivos Therapeutics (VVOS) - The Globe and Mail
Is Vivos Therapeutics Inc. stock a safe buy before earningsWeekly Stock Report & Long Hold Capital Preservation Tips - Улправда
Is Vivos Therapeutics Inc. stock a buy in volatile markets2025 Price Momentum & Weekly Stock Breakout Alerts - ulpravda.ru
Why analysts remain bullish on Vivos Therapeutics Inc. stockJuly 2025 Review & Safe Swing Trade Setup Alerts - Улправда
Can Vivos Therapeutics Inc. stock weather global recessionJuly 2025 Patterns & Growth Oriented Trade Recommendations - Улправда
Published on: 2026-01-08 23:11:17 - Улправда
Aug Update: Can Vivos Therapeutics Inc. stock weather global recessionPortfolio Profit Report & Fast Gaining Stock Reports - ulpravda.ru
Best Biotech Penny Stocks Right Now • Updated Daily - Benzinga
비보스 테라퓨틱스 (VVOS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.33%
0.51%
자본화:
|
볼륨(24시간):